# Intramuscular Transplantation of Muscle Derived Stem Cell and Adipose Derived Mesenchymal Stem Cells in Patients With Facioscapulohumeral Dystrophy (FSHD)

> **NCT02208713** · PHASE1 · UNKNOWN · sponsor: **Royan Institute** · enrollment: 21 (estimated)

## Conditions studied

- Dystrophy

## Interventions

- **BIOLOGICAL:** Intramuscular injection

## Key facts

- **NCT ID:** NCT02208713
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2017-11
- **Final completion:** 2017-12
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2017-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02208713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02208713, "Intramuscular Transplantation of Muscle Derived Stem Cell and Adipose Derived Mesenchymal Stem Cells in Patients With Facioscapulohumeral Dystrophy (FSHD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02208713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*